A Phase I Study of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate in Patients with Advanced Hematologic Malignancies

Aaron D. Schimmer ; Susan O'Brien ; Hagop Kantarjian ; Joseph Brandwein ; Bruce D. Cheson ; Mark D. Minden ; Karen Yee ; Farhad Ravandi ; Francis Giles ; Andre Schuh ; Vikas Gupta ; Michael Andreeff ; Charles Koller ; Hong Chang ; Suzanne Kamel-Reid ; Mark Berger ; Jean Viallet ; Gautam Borthakur

Clinical cancer research, 2008-12, Vol.14 (24), p.8295-8301 [Periódico revisado por pares]

United States: American Association for Cancer Research

Texto completo disponível